While direct evidence in the context of liver disease is still lacking, these findings suggest that HuR may regulate C/EBPβ expression and thereby influence the development and progression of NAFLD. The gene discussed is ELAVL1; the disease is metabolic dysfunction-associated steatotic liver disease.